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Many patients and their clinicians would be grateful for a non-invasive method of detecting the extent of primary and secondary malignant tumours. The knowledge gained would enable treatment to be tailored to the exact needs of the individual patient. It would be ideal if the treatment could be delivered in such a way that only the areas affected by the tumour were treated. Ehrlich's dream of "magic bullets" may now be nearing reality thanks to the manufacture of tumour specific antibodies using the monoclonal antibody technique developed by Kohler and Milstein. Attempts to radiolabel the antibodies and detect their localisation in vivo--"radioimmunodetection"-have not 20 One of the main limitations of the available monoclonal antibodies is that tumour cells are able to modulate a membrane antigen-that is, alter its antigenic expression in the presence of a monoclonal antibody. There is therefore a danger that using an antibody for tumour detection may induce modulation making the tumour resistant should the same antibody later be used for treatment. Further monitoring of the effect oftreatment on tumour size using labelled antibodies would also be impeded.
Circulating antigen in the blood will bind with the antibody, forming immune complexes which will interfere with radiolocalisation especially over the liver, because of the uptake of the complexes by the reticuloendothelial system and the non-specific binding to hepatocytes and monocytes through the Fc portion of the molecule.2' 22 Hine wards. The importance of prophylaxis should be emphasised to the patient since otherwise the thyroid may receive unacceptable levels of radiation.6 Patients need to be tested for sensitivity to the foreign protein before scanning is performed. In over 400 patients only two instances of a skin reaction to the antibody have been noted. In 50 patients who have received two or three imaging studies no reactions have been observed. 15 Promising work is being done to overcome many of the main difficulties with the sensitivity and specificity of radioimmunodetection. This 
